Hehlmann, R., Hochhaus, A., Kolb, H., Hasford, J., Gratwohl, A., Heimpel, H., . . . Tobler, W. (1999). Interferon-α before allogeneic bone marrow Ttransplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure. Blood, 94(11), . https://doi.org/10.1182/blood.V94.11.3668
Chicago-Zitierstil (17. Ausg.)Hehlmann, Rüdiger, et al. "Interferon-α Before Allogeneic Bone Marrow Ttransplantation in Chronic Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Discontinued at Least 90 Days Before the Procedure." Blood 94, no. 11 (1999). https://doi.org/10.1182/blood.V94.11.3668.
MLA-Zitierstil (9. Ausg.)Hehlmann, Rüdiger, et al. "Interferon-α Before Allogeneic Bone Marrow Ttransplantation in Chronic Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Discontinued at Least 90 Days Before the Procedure." Blood, vol. 94, no. 11, 1999, https://doi.org/10.1182/blood.V94.11.3668.